Ah Brilliant, thanks so much @joewolf and @rl (not sure that tag worked).
This is a pretty awesome deal IMO. I've been a holder of two other med companies (CAJ and LHC) and both are valued at substantial premiums to the combined entity PGC just formed.
CAJ is worth ~$380million (has been as high as $470 million) on $111 million revenue and 16.2million NPBT (3.8mil NPAT due to acqui)
LHC is worth ~150million (has been as high as $175 million) on $83million revenue and $16.5 mil EBITDA
The combined entity will be worth ~100million at todays prices (if it holds) so I still see some room for growth given the revenue and margins seems to be in line with peers valued at higher MC.
All 3 are targetting slightly different markets also, although with the new acquisitions PGC may be cutting into CAJ market so could be some competition there.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)